In this scientific statement from the American Heart Association, experts in the field of
cardiomyopathy (heart muscle disease) in children address 2 issues: the most current …

Heart failure is a global pandemic affecting an estimated 26 million people worldwide and
resulting in more than 1 million hospitalizations annually in both the United States and …

While many diseases of aging have been linked to the immunological system, immune
metrics capable of identifying the most at-risk individuals are lacking. From the blood …

Background Point-of-care ultrasound (POCUS) is nowadays an essential tool in critical care.
Its role seems more important in neonates and children where other monitoring techniques …

Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

Background Heart failure (HF) is a major health burden worldwide. However, there is no
nationwide epidemiological data on HF in China after 2000. The aims of this study are (i) to …

Heart transplantation is the only cure for patients with terminal cardiac failure, but the supply
of allogeneic donor organs falls far short of the clinical need 1, 2, 3. Xenotransplantation of …

Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure
(HF) with preserved ejection fraction (HFpEF) has been limited. We aimed to investigate the …

Purpose Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies
that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual …